Elanco Animal Health (ELAN) EBITDA Margin: 2016-2024
Historic EBITDA Margin for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to -34.13%.
- Elanco Animal Health's EBITDA Margin rose 818.00% to 14.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.85%, marking a year-over-year increase of 3791.00%. This contributed to the annual value of -34.13% for FY2024, which is 3664.00% up from last year.
- Per Elanco Animal Health's latest filing, its EBITDA Margin stood at -34.13% for FY2024, which was up 51.78% from -70.77% recorded in FY2023.
- Elanco Animal Health's 5-year EBITDA Margin high stood at -34.13% for FY2024, and its period low was -71.66% during FY2020.
- Moreover, its 3-year median value for EBITDA Margin was -45.00% (2022), whereas its average is -49.97%.
- As far as peak fluctuations go, Elanco Animal Health's EBITDA Margin tumbled by 2,633bps in 2020, and later soared by 3,664bps in 2024.
- Yearly analysis of 5 years shows Elanco Animal Health's EBITDA Margin stood at -71.66% in 2020, then skyrocketed by 1,492bps to -56.74% in 2021, then surged by 1,174bps to -45.00% in 2022, then tumbled by 2,577bps to -70.77% in 2023, then surged by 3,664bps to -34.13% in 2024.